SWOG clinical trial number
CTSU/A021806

A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer

Open
Abbreviated Title
A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer
Status Notes
This study is active in SWOG as of July 1, 2020.
Activated
07/01/2020

Research committees

Gastrointestinal Cancer

Eligibility Criteria Expand/Collapse

Please see eligibility criteria in protocol on www.CTSU.org

Other Clinical Trials

SWOG Clinical Trial Number
CTSU/A021806

A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer

Research Committee(s)
Gastrointestinal Cancer
Activated
07/01/2020
Open
SWOG Clinical Trial Number
S1922

Randomized Phase II Study of Ramucirumab and Paclitaxel versus FOLFIRI in Refractory Small Bowel Adenocarcinoma

Research Committee(s)
Gastrointestinal Cancer
Activated
12/16/2019
Accrual
9%
Open
Phase
II